Breast Cancer Risk From Modifiable and Nonmodifiable Risk Factors Among White Women in the United States

scientific article

Breast Cancer Risk From Modifiable and Nonmodifiable Risk Factors Among White Women in the United States is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1001/JAMAONCOL.2016.1025
P932PMC publication ID5719876
P698PubMed publication ID27228256

P50authorWalter C. WillettQ1133904
David J. HunterQ21066148
Nilanjan ChatterjeeQ21526241
Stephen ChanockQ27662321
Kim OvervadQ28356149
Rosario TuminoQ28356361
Federico CanzianQ28360459
Graham GilesQ30524411
Melissa C. SoutheyQ55446228
Tyler VanderWeeleQ56363392
Roger L. MilneQ56855807
María José Sánchez PérezQ57549270
Fredrick SchumacherQ64183024
Myrto BarrdahlQ67212440
Julie E. BuringQ67224421
Jonine FigueroaQ71778357
David G. CoxQ73023435
Christopher A. HaimanQ73606228
Brian E. HendersonQ73660621
Laura BagliettoQ74010954
Susan E. HankinsonQ76570836
Sara LindstroemQ77022171
Peter KraftQ77526208
Daniel StramQ85936408
Claudine IsaacsQ90579511
Mia M. GaudetQ90611381
Susan M GapsturQ90864325
Regina G. ZieglerQ90946208
Paul L AuerQ99370519
Barry I. GraubardQ100467671
Isabelle RomieuQ107417173
Christine BergQ109563446
Laurence N KolonelQ114130594
Robert N. HooverQ118558329
P2093author name stringAmit D Joshi
Mitchell H Gail
Ross L Prentice
Paige Maas
I-Min Lee
William F Anderson
Shumin Zhang
David Check
Montse Garcia-Closas
Subham Chattopadhyay
P2860cites work16. The fraction of cancer attributable to lifestyle and environmental factors in the UK in 2010Q22251112
Genome-wide association studies identify four ER negative-specific breast cancer risk lociQ24622610
Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012Q27861047
Proportion of breast cancer cases in the United States explained by well-established risk factorsQ28283778
Large-scale genotyping identifies 41 new loci associated with breast cancer riskQ29416989
Identification of new genetic susceptibility loci for breast cancer through consideration of gene-environment interactionsQ34038964
Performance of common genetic variants in breast-cancer risk modelsQ34064069
Post-GWAS gene-environment interplay in breast cancer: results from the Breast and Prostate Cancer Cohort Consortium and a meta-analysis on 79,000 womenQ34155371
Effect of direct-to-consumer genomewide profiling to assess disease riskQ34158574
Inclusion of endogenous hormone levels in risk prediction models of postmenopausal breast cancerQ34225990
Additive interactions between susceptibility single-nucleotide polymorphisms identified in genome-wide association studies and breast cancer risk factors in the Breast and Prostate Cancer Cohort ConsortiumQ34472668
Testing calibration of risk models at extremes of disease riskQ34678258
Combined associations of genetic and environmental risk factors: implications for prevention of breast cancerQ34736112
Investigation of gene-environment interactions between 47 newly identified breast cancer susceptibility loci and environmental risk factorsQ34898735
Associations between self-referral and health behavior responses to genetic risk informationQ35030090
Risk factor modification and projections of absolute breast cancer riskQ35090578
Interactions between genetic variants and breast cancer risk factors in the breast and prostate cancer cohort consortiumQ35166701
Population sciences, translational research, and the opportunities and challenges for genomics to reduce the burden of cancer in the 21st centuryQ35291344
Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancerQ35996692
Does Type 2 Diabetes Genetic Testing and Counseling Reduce Modifiable Risk Factors? A Randomized Controlled Trial of VeteransQ36199476
Breast cancer risk prediction and individualised screening based on common genetic variation and breast density measurementQ36393193
Prediction of breast cancer risk based on profiling with common genetic variantsQ36583004
Evidence of gene-environment interactions between common breast cancer susceptibility loci and established environmental risk factorsQ36720821
Discriminatory accuracy from single-nucleotide polymorphisms in models to predict breast cancer riskQ36858843
Prediction of breast cancer risk by genetic risk factors, overall and by hormone receptor statusQ37223335
A large-scale assessment of two-way SNP interactions in breast cancer susceptibility using 46,450 cases and 42,461 controls from the breast cancer association consortiumQ37619303
The behavioral response to personalized genetic information: will genetic risk profiles motivate individuals and families to choose more healthful behaviors?Q37673185
Global estimates of cancer prevalence for 27 sites in the adult population in 2008.Q38920305
Design and estimation for the national health interview survey, 2006-2015.Q51091404
A candidate gene approach to searching for low-penetrance breast and prostate cancer genesQ57306192
Questionnaires from the National Health Interview Survey, 1985-89Q72597326
Polygenes, risk prediction, and targeted prevention of breast cancerQ81523323
Public health implications from COGS and potential for risk stratification and screeningQ86499074
P433issue10
P304page(s)1295-1302
P577publication date2016-05-26
P1433published inJAMA OncologyQ22079683
P1476titleBreast Cancer Risk From Modifiable and Nonmodifiable Risk Factors Among White Women in the United States
P478volume2

Reverse relations

cites work (P2860)
Q37697979A clinical model for identifying the short-term risk of breast cancer
Q92199197A systematic review and quality assessment of individualised breast cancer risk prediction models
Q57748350Addition of a polygenic risk score, mammographic density, and endogenous hormones to existing breast cancer risk prediction models: A nested case-control study
Q90051408Assessing thyroid cancer risk using polygenic risk scores
Q91866775Assessment of breast cancer risk: which tools to use?
Q97070156Assessment of polygenic architecture and risk prediction based on common variants across fourteen cancers
Q90598883Association and implications in triple negative and triple positive breast cancer: Relationship with sociodemographic and reproductive factors in Pakistan
Q57612089Association of Polygenic Risk Scores for Multiple Cancers in a Phenome-wide Study: Results from The Michigan Genomics Initiative
Q38765326Association of alcohol intake with risk of diabetic retinopathy: a meta-analysis of observational studies
Q57114175Awareness and Misconceptions of Breast Cancer Risk Factors Among Laypersons and Physicians
Q91045517BOADICEA: a comprehensive breast cancer risk prediction model incorporating genetic and nongenetic risk factors
Q91865303Benefits and limitations of genome-wide association studies
Q87909686Breast Cancer Risk Model Requirements for Counseling, Prevention, and Screening
Q91650503Breast cancer risk status influences uptake, retention and efficacy of a weight loss programme amongst breast cancer screening attendees: two randomised controlled feasibility trials
Q101237548Cancer therapy shapes the fitness landscape of clonal hematopoiesis
Q90300115Choosing Breast Cancer Risk Models: Importance of Independent Validation
Q92709250Clinical use of current polygenic risk scores may exacerbate health disparities
Q92240128Combined effect of modifiable and non-modifiable risk factors for colorectal cancer risk in a pooled analysis of 11 population-based studies
Q92528444Comparative Validation of Breast Cancer Risk Prediction Models and Projections for Future Risk Stratification
Q57177092Cost-effectiveness and Benefit-to-Harm Ratio of Risk-Stratified Screening for Breast Cancer: A Life-Table Model
Q47251942Current Challenges and New Opportunities for Gene-Environment Interaction Studies of Complex Diseases
Q45072344Current Gaps in Ovarian Cancer Epidemiology: The Need for New Population-Based Research.
Q47724615Development of a predictive miRNA signature for breast cancer risk among high-risk women
Q91831253Diagnostic high-throughput sequencing of 2396 patients with bleeding, thrombotic, and platelet disorders
Q89798942Efficient Estimation and Applications of Cross-Validated Genetic Predictions to Polygenic Risk Scores and Linear Mixed Models
Q88994510Emerging Trends in Clinical Research: With Implications for Population Health and Health Policy
Q90367200Estimation of Absolute Risk of Colorectal Cancer Based on Healthy Lifestyle, Genetic Risk, and Colonoscopy Status in a Population-based Study
Q90929499Estimation of complex effect-size distributions using summary-level statistics from genome-wide association studies across 32 complex traits
Q54911668Evaluating Public Health Interventions: 6. Modeling Ratios or Differences? Let the Data Tell Us.
Q37609227FOXC1 is associated with estrogen receptor alpha and affects sensitivity of tamoxifen treatment in breast cancer
Q48212258Family history influences the tumor characteristics and prognosis of breast cancers developing during postmenopausal hormone therapy
Q64080586Genetic Testing to Guide Risk-Stratified Screens for Breast Cancer
Q96821073Genetic Variant in CHRNA5 and Response to Varenicline and Combination Nicotine Replacement in a randomized placebo-controlled trial
Q100407592Genetic risk, incident gastric cancer, and healthy lifestyle: a meta-analysis of genome-wide association studies and prospective cohort study
Q64236058Genomic Predictors of Asthma Phenotypes and Treatment Response
Q92046438Identification of risk loci and a polygenic risk score for lung cancer: a large-scale prospective cohort study in Chinese populations
Q92711915Incidence of breast cancer attributable to breast density, modifiable and non-modifiable breast cancer risk factors in Singapore
Q37360550Integrating precision cancer medicine into healthcare-policy, practice, and research challenges
Q104073603Integrative genomic analysis implicates ERCC6 and its interaction with ERCC8 in susceptibility to breast cancer
Q64279327Joint association of mammographic density adjusted for age and body mass index and polygenic risk score with breast cancer risk
Q47190168Joint associations of a polygenic risk score and environmental risk factors for breast cancer in the Breast Cancer Association Consortium
Q33829049Joint modeling of genetically correlated diseases and functional annotations increases accuracy of polygenic risk prediction
Q96230819Large-scale genome-wide association study in a Japanese population identifies novel susceptibility loci across different diseases
Q43843244Limited influence of germline genetic variation on all-cause mortality in women with early onset breast cancer: evidence from gene-based tests, single-marker regression, and whole-genome prediction
Q64945839Machine learning techniques for personalized breast cancer risk prediction: comparison with the BCRAT and BOADICEA models.
Q96604435Machine learning-based lifetime breast cancer risk reclassification compared with the BOADICEA model: impact on screening recommendations
Q64986687Nutrient intake patterns and breast cancer risk among Jordanian women: a case-control study.
Q96577047Personalized early detection and prevention of breast cancer: ENVISION consensus statement
Q62583133Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes
Q92287495Polygenic Susceptibility of Aortic Aneurysms Associates to the Diameter of the Aneurysm Sac: the Aneurysm-Express Biobank Cohort
Q91788154Polygenic and clinical risk scores and their impact on age at onset and prediction of cardiometabolic diseases and common cancers
Q92638472Polygenic prediction of breast cancer: comparison of genetic predictors and implications for risk stratification
Q91791147Precision neuroradiology: mapping the nodes and networks that link genes to behaviour
Q47409320Predictive accuracy of combined genetic and environmental risk scores
Q57296967Preventative Health and Risk Behaviors Among Adolescent Girls With and Without Family Histories of Breast Cancer
Q49923389Quantifying the polygenic contribution to cutaneous squamous cell carcinoma risk.
Q53826302Reproductive risk factors in breast cancer and genetic hormonal pathways: a gene-environment interaction in the MCC-Spain project.
Q61118451Shared heritability and functional enrichment across six solid cancers
Q47161591The ANDROMEDA prospective cohort study: predictive value of combined criteria to tailor breast cancer screening and new opportunities from circulating markers: study protocol.
Q61755960The Genetic Sphygmomanometer: an argument for routine genome-wide genotyping in the population and a new view on its use to inform clinical practice
Q57299380The approach to predictive medicine that is taking genomics research by storm
Q64117891The endocytic membrane trafficking pathway plays a major role in the risk of Parkinson's disease
Q88778863The personal and clinical utility of polygenic risk scores
Q47661659Update on the State of the Science for Analytical Methods for Gene-Environment Interactions
Q92043569Use of detailed family history data to improve risk prediction,with application to breast cancer screening
Q50281308Validating a breast cancer score in Spanish women. The MCC-Spain study.
Q57040851Validation of a genetic risk score for Arkansas women of color
Q97093695Validation of the BOADICEA model and a 313-variant polygenic risk score for breast cancer risk prediction in a Dutch prospective cohort
Q58400951Will Precision Medicine Improve Population Health?
Q89547730iCARE: An R package to build, validate and apply absolute risk models

Search more.